Amanda Piquet is a Neurology physician affiliated with University of Colorado Anschutz Medical Campus. OpenAlex indexes 134 publications with 987 citations (h-index 17).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
12605 E 16th Ave
Aurora, CO 800452545
Telephone
720-848-0000Registry record last updated 21 Jul 2022.
Industry payments
18 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Amgen Inc.Program year202513 payments
- Alexion Pharmaceuticals, Inc.Program year20254 payments
- F. Hoffmann-La Roche AGProgram year20254 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
54.9%Benzodiazepine27%Clonazepam71%Diazepam29%Part D<11 patientsGabapentinoids17.6%Gabapentin63%Pregabalin37%Part D<11 patients+ 1 more class in this area
Musculoskeletal
21.3%gamma-Aminobutyric Acid-ergic Agonist13.9%Baclofen100%Part D<11 patientsCyclooxygenase Inhibitor7.4%Ketorolac Tromethamine100%Part D<11 patientsBlood & clotting
9.4%Salt solutions9.4%Sodium Chloride100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2023–2026 per NIH RePORTER. The latest:
- University of Colorado Rocky Mountain NeuroNEXT (UNCOMON) Clinical Research Consortium.
University of Colorado Denver
FY2026$428,955U24NS133991 - University of Colorado Rocky Mountain NeuroNEXT (UNCOMON) Clinical Research Consortium.
University of Colorado Denver
FY2025$428,955U24NS133991 - University of Colorado Rocky Mountain NeuroNEXT (UNCOMON) Clinical Research Consortium.
University of Colorado Denver
FY2024$416,086U24NS133991
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Complement Inhibition for Acute Neuromyelitis Optica Spectrum Disorder Attacks
Neurology Neuroimmunology & Neuroinflammation
2026 - Clinical Characterization and Long-Term Outcome in Children and Adults With Anti-AMPA Receptor Encephalitis
Neurology Neuroimmunology & Neuroinflammation
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Richard Schulick, MD, MBA
University of Colorado Anschutz Medical Campus
John Rumsfeld, MD, PhD
University of Colorado Anschutz Medical Campus
Robert Eckel, MD
University of Colorado Anschutz Medical Campus
Marc Bonaca, MD
University of Colorado Anschutz Medical Campus
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”